MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.250
+0.090 (2.16%)
At close: May 15, 2026, 4:00 PM EDT
4.350
+0.100 (2.35%)
After-hours: May 15, 2026, 7:46 PM EDT

MacroGenics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-70.36-74.62-66.97-9.06-119.76-202.12
Depreciation & Amortization
7.097.177.549.6511.8711.26
Stock-Based Compensation
12.5514.2929.4418.3720.4423.13
Other Adjustments
1.980.45-39.78-150.486.636.33
Change in Receivables
0.12-9.066.0645.86-45.8412.7
Changes in Inventories
-0.07-7.91-2.190.230.06-6.42
Changes in Accounts Payable
-2.31-0.28-1.531.28-10.867.13
Changes in Accrued Expenses
-9.39-6.835-4.82-4.64-0.61
Changes in Unearned Revenue
-3.57-5.4-9.4111.4348.829.26
Changes in Other Operating Activities
-2.651.153.46-0.656.33-4.49
Operating Cash Flow
-69.96-81.04-68.37-78.21-86.96-143.83
Capital Expenditures
-1.73-1.91-3.71-1.76-3.62-6.2
Sale of Property, Plant & Equipment
0.010.010.160.06--
Purchases of Investments
-202.4-208.34-77.18-239.68-120.6-231.21
Proceeds from Sale of Investments
125.4496.14190.03161.3194.94200.8
Proceeds from Business Divestments
--40---
Investing Cash Flow
-78.68-114.1149.3-80.0870.72-36.61
Issuance of Common Stock
0.140.133.441.171.66122.78
Repurchase of Common Stock
-0.22-0.29-2.48-0.31--
Net Common Stock Issued (Repurchased)
-0.08-0.160.960.861.66122.78
Other Financing Activities
34.8469.67-149.5--
Financing Cash Flow
69.5969.510.96150.361.66122.78
Net Cash Flow
-79.05-125.6281.88-7.93-14.59-57.66
Free Cash Flow
-71.69-82.95-72.08-79.97-90.58-150.03
FCF Margin
-45.64%-55.49%-48.06%-136.12%-59.62%-193.72%
Free Cash Flow Per Share
-1.13-1.31-1.15-1.29-1.47-2.50
Levered Free Cash Flow
-82.99-88.63-67.86.28-71.81-192.19
Unlevered Free Cash Flow
-75.69-86.2-112.99-152.9-73.47-192.87
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q